内分泌代谢论坛
ENGLISH ABSTRACT
阴阳兼顾 方能坚固
解读《男性骨质疏松症诊疗指南》
章振林
作者及单位信息
·
DOI: 10.3760/cma.j.cn311282-20210908-00589
Interpretation of Guidelines for the Diagnosis and Treatment of Male Osteoporosis
Zhang Zhenlin
Authors Info & Affiliations
Zhang Zhenlin
Shanghai Clinical Research Center of Bone Disease, Department of Osteoporosis and Bone Diseases, Shanghai Jiaotong University Affiliated Sixth People′s Hospital, Shanghai 200233, China
·
DOI: 10.3760/cma.j.cn311282-20210908-00589
627
166
0
0
9
0
PDF下载
APP内阅读
摘要

2020年10月中华医学会骨质疏松和骨矿盐疾病分会发布了《男性骨质疏松症诊疗指南》,本文结合《原发性骨质疏松症诊疗指南(2017)》,对《男性骨质疏松症诊疗指南》从骨质疏松流行病学、发病机制、临床表现、诊断和鉴别诊断,以及治疗等方面进行解读。

指南解读;男性骨质疏松症
ABSTRACT

In October 2020, Chinese Society of Osteoporosis and Bone Mineral Research issued the Guidelines for Diagnosis and Treatment of Male Osteoporosis. Taken together with the Guideline for Diagnosis and Treatment of Primary Osteoporosis (2017), this article interprets guideline for male osteoporosis from the aspects of osteoporosis epidemiology, pathogenesis, clinical manifestations, diagnosis, differential diagnosis, and treatment.

Interpretation of guidelines;Male osteoporosis
Zhang Zhenlin, Email: nc.defudabe.utjslzgnahz
引用本文

章振林. 阴阳兼顾 方能坚固 : 解读《男性骨质疏松症诊疗指南》[J]. 中华内分泌代谢杂志,2022,38(02):89-92.

DOI:10.3760/cma.j.cn311282-20210908-00589

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
2020年10月在杭州中华医学会骨质疏松和骨矿盐疾病分会全国年会上隆重发布了《男性骨质疏松症诊疗指南》 [ 1 ],这是国内首次发布的专门针对男性骨质疏松患者的诊疗指南,将指导我们临床对男性骨质疏松症的规范诊断与治疗等,指南一经发布就深受广大医务人员欢迎,截止目前下载量已超2万次。本文以《男性骨质疏松症诊疗指南》为基础,结合《原发性骨质疏松症诊疗指南(2017)》 [ 2 ],主要从骨质疏松流行病学、发病机制、临床表现、诊断和鉴别诊断,以及治疗等进行解读,希望对读者有所裨益。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
中华医学会骨质疏松和骨矿盐疾病分会. 男性骨质疏松症诊疗指南[J]. 中华内分泌代谢杂志 202036(10):817-827. DOI: 10.3760/cma.j.cn311282-20200914-00633 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华内分泌代谢杂志 201733(10):890-913. DOI: 10.3760/cma.j.issn.1000-6699.2017.10.017 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Kanis JA . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group[J]. Osteoporos Int, 19944(6):368-381. DOI: 10.1007/BF01622200 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference[J]. South Med J, 200194(6):569-573.
[5]
Jean-Marc K . Management of osteoporosis in older men[J]. Aging Clin Exp Res, 202133(6):1439-1452. DOI: 10.1007/S40520-021-01845-8 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Wang L , Yu W , Yin X ,et al. Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study[J]. JAMA Netw Open, 20214(8):e2121106. DOI: 10.1001/jamanetworkopen.2021.21106 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Zeng Q , Li N , Wang Q ,et al. The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey[J]. J Bone Miner Res, 201934(10):1789-1797. DOI: 10.1002/jbmr.3757 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Gao C , Xu Y , Li L ,et al. Prevalence of osteoporotic vertebral fracture among community-dwelling elderly in Shanghai[J]. Chin Med J (Engl), 2019132(14):1749-1751. DOI: 10.1097/CM9.0000000000000332 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Xia WB , He SL , Xu L ,et al. Rapidly increasing rates of hip fracture in Beijing, China[J]. J Bone Miner Res, 201227(1):125-129. DOI: 10.1002/jbmr.519 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Keene GS , Parker MJ , Pryor GA . Mortality and morbidity after hip fractures[J]. BMJ, 1993307(6914):1248-1250. DOI: 10.1136/bmj.307.6914.1248 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Osnes EK , Lofthus CM , Meyer HE ,et al. Consequences of hip fracture on activities of daily life and residential needs[J]. Osteoporos Int, 200415(7):567-574. DOI: 10.1007/s00198-003-1583-0 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Tarazona-Santabalbina F , Belenguer-Varea A , Rovira-Daudi E ,et al. Early interdisciplinary hospital intervention for elderly patients with hip fractures: functional outcome and mortality[J]. Clinics, 201267(6):547-556. DOI: 10.6061/clinics/2012(06)02 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Zhang C , Feng J , Wang S ,et al. Incidence of and trends in hip fracture among adults in urban China: A nationwide retrospective cohort study[J]. PLoS Med, 202017(8):e1003180. DOI: 10.1371/journal.pmed.1003180 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
李梅. 男性骨质疏松诊疗进展[J]. 中国临床医生 200634(7):15-17. DOI: 10.3969/j.issn.1008-1089.2006.07.007 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Manolagas SC . From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis[J]. Endocr Rev, 201031(3):266-300. DOI: 10.1210/er.2009-0024 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Zhang ZL , Qin YJ , Huang QR ,et al. Bone mineral density of the spine and femur in healthy Chinese men[J]. Asian J Androl, 20068(4):419-427. DOI: 10.1111/j.1745-7262.2006.00170.x .
返回引文位置Google Scholar
百度学术
万方数据
[17]
黄琪仁周琦陆敬辉. 2111例上海健康女性骨密度值测定与年龄相关骨丢失的研究[J]. 中国骨质疏松杂志 20028(3):191-194. DOI: 10.3969/j.issn.1006-7108.2002.03.001 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Kharroubi A , Saba E , Ghannam I ,et al. Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF One Minute Test, SCORE, and FRAX) in postmenopausal Palestinian women[J]. Arch Osteoporos, 201712(1):6. DOI: 10.1007/s11657-016-0298-8 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Nayak S , Edwards DL , Saleh AA ,et al. Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density[J]. Osteoporos Int, 201526(5):1543-1554. DOI: 10.1007/s00198-015-3025-1 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Kanis JA , Harvey NC , Cooper C ,et al. A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation[J]. Arch Osteoporos, 201611(1):25. DOI: 10.1007/s11657-016-0278-z .
返回引文位置Google Scholar
百度学术
万方数据
[21]
李育红章振林. 骨折风险评估工具(FRAX(R))对男性骨折的预测价值[J]. 中华骨质疏松和骨矿盐疾病杂志 20136(4):303-307. DOI: 10.3969/j.issn.1674-2591.2013.04.005 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
中华医学会骨质疏松和骨矿盐疾病分会. 骨转换生化标志物临床应用指南[J]. 中华内分泌代谢杂志 202137(10):863-874. DOI: 10.3760/cma.j.cn311282-20210915-00599 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Siris ES , Harris ST , Rosen CJ ,et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases[J]. Mayo Clin Proc, 200681(8):1013-1022. DOI: 10.4065/81.8.1013 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
章振林,Email: nc.defudabe.utjslzgnahz
B
所有作者均声明不存在利益冲突
C
国家重点研发计划 (2018YFA0800801)
上海申康医院发展中心临床科技创新项目 (SHDC12018120)
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号